European Consortium of Lipodystrophies (ECLip)
  • Home
  • Goals
  • Lipodystrophies
    • Classification
  • Groups
    • Austria
      • Foisner
      • Scherer
    • Belgium
      • Unité de Recherche en Biologie Cellulaire (Namur)
      • Cell Systems and Imaging (Ghent)
      • Universitair Ziekenhuis Antwerpen (Antwerp)
    • Bulgaria
    • Cyprus
    • Egypt
    • France
      • Genetic and Acquired Lipodystrophies (Paris)
      • Genetics, Pathophysiology and Therapeutic Approach
      • Paediatric Endocrinology Unit (Paris)
      • INSERM UMR_S 1087 (Nantes)
      • Lille Group (Lille)
      • ​Premature Aging Syndromes & Lipodystrophies​
      • Pediatric Endocrinology and Diabetology (Paris)
    • Germany
      • Hoffmann Group (Halle)
      • Clinic for Transplantation Medicine (Münster)
      • Dep. of Pediatrics and Adolescent Medicine (Ulm)
      • IFB Lipodystrophy Centre (Leipzig)
    • Greece
      • ​Paediatric HIV Referral Unit (Athens)
      • Unit of Reproductive Endocrinology (Thessaloniki)
    • Israel
    • Italy
      • Laminopathy Research Laboratory (Bologna)
      • Human Lipodystrophies (Bologna)
      • Obesity Center-Endocrinology Unit (Pisa)
      • Laboratory of Medical Genetics (Roma)
      • Gene Expression - Microarrays Laboratory (Roma)
    • Lithuania
    • Netherlands
      • AMC Lipodystrophy Group (Amsterdam)
      • Maastricht University Hospital
      • Leiden University Medical Center
      • Amsterdam UMC
    • Norway
    • Oman
    • Peru
    • Poland
    • Portugal
      • Porto University
      • Grupo de Estudo das Lipodistrofias do CMIN (Porto)
    • Russia
    • Slovenia
    • Spain
      • UETeM - Molecular Pathology Group (Santiago)
      • Stem Cell Laboratory (Vizcaya)
      • Rheumatology Division Proteomics Group (A Coruña)
      • Department of Medical Sciences (Ciudad Real)
      • Adipobiology Group (Córdoba)
      • Uniovi (Oviedo)
      • Dep. Biochemistry & Molecular Biology (Barcelona)
      • Clinical Genetics and Rare Diseases (Murcia)
      • Fundación Galega de Medicina Xenómica (Santiago)
      • Complement system IdiPAZ (Madrid)
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom
      • Nat. Severe Insulin Resistance Service (Cambridge)
      • Centre for Cardiovascular Science (Edinburgh)
      • University of Aberdeen
    • USA
      • NIDDK (Maryland)
      • University of Michigan
  • Information
    • Advocacy groups
    • Clinical centres
    • Executive board
      • Disclosure
    • Registry
  • News
  • Meetings
    • 2015 World Lipodystrophy Day
    • 2016 ECLip Annual Meeting
    • 2017 ECLip Annual Meeting
    • 2018 ECLip Annual Meeting
    • 2019 ECLip Annual Meeting
      • Gallery
    • 2020 ECLip Annual Meeting
    • 2022 ECLip Annual Meeting
    • 2023 ECLip Annual Meeting
  • Publications
    • POW: Paper of the week
    • Collaborative ECLip Publications
  • Contact

SPAIN


UETeM-Molecular Pathology Group (Santiago de Compostela)

Stem Cell Laboratoy (Vizcaya)

Rheumatology Division Proteomics Group - ProteoRed ISCIII (A Coruña)

Department of Medical Sciences (Ciudad Real)

Adipobiology Group (Córdoba)

Uniovi (Oviedo)

Department of Biochemistry and Molecular Biology (Barcelona)

Clinical Genetics and Rare Diseases (Murcia)

Fundación Galega de Medicina Xenómica (Santiago de Compostela)

Complement System Research Group, IdiPAZ (Madrid)

2019 European Consortium of Lipodystrophies (ECLip)